The rising prevalence of peripheral artery disease and the increasing incidence of chronic limb ischemia has necessitated innovation in skin perfusion pressure testing devices. Chronic limb ischemia is the most advanced form of peripheral artery disease, and leads to mortality, morbidity, and high healthcare resource utilization. The assessment for wound healing in limb ischemia requires the skin perfusion pressure method for checking blood flow pressure in the limbs.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for skin perfusion pressure testing devices. The report tracks the global sales of skin perfusion pressure testing devices in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and skin perfusion pressure testing devices in particular.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Peripheral artery disease (PAD) is a progressive disorder affecting more than 200 million people, worldwide. It has a significant impact on mortality in hemodialysis patients. Approximately 6.5 million people aged 40 years and older in the United States have PAD. The increasing PAD population has propelled the growth of the skin perfusion pressure testing market.
Skin perfusion pressure has become a potential tool for wound healing in patients with chronic limb ischemia. Compared to other non-invasive methods such as toe blood pressure and ankle-brachial index, skin perfusion pressure provides more accurate results, thus, its usage is gaining popularity among physicians.
This technique also remains a clinically relevant and objective tool of local perfusion in the setting of chronic limb ischemia, particularly among higher-risk patients with arterial calicifications and comorbidities that tend to microvascular disease. FMI expects global skin perfusion pressure testing devices market to grow at 4.5% CAGR through 2030.
Principal Consultant
Non-invasive procedures have continued to grow in popularity as compared to surgeries. The measurement of skin perfusion pressure by a laser doppler is a non-invasive method that is widely used by professionals. Due to high reproducibility, accuracy, specificity, and sensitivity, skin perfusion pressure testing has become one of the soundest methods.
For instance, non-invasive VMS-VASC system (Moor) Instruments), including the laser Doppler monitor moorVMS-LDF, low profile fibre optic probe (VP-SPP), and pressure cuff controller moorVMS-PRES have been specifically designed to aid micro vascular assessments in a variety of clinical applications and physiological research.
Laser dopplers have proven to be effective devices for the measurement of skin perfusion pressure. Laser dopplers are among the regularly utilized gadgets for the appraisal of skin perfusion pressure, they are seen as the ideal instrument for the location of peripheral artery disease as well as diagnosis of wound healing potential in limb ischemia patients.
Furthermore, the accuracy in a laser doppler is much higher than any other traditional method. The high accuracy, simplicity of operability and non-invasiveness feature of the devices are likely to fuel the utilization of laser dopplers by the physicians, boosting the demand of the skin perfusion testing devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Due to an increase in the need for assessment of wound healing in peripheral artery disease and limb ischemia, many manufacturers are seeking 510(k) Premarket Notification to FDA which demonstrates the device to be safe and effective as equivalent to a legally-marketed device
For example, Perimed Inc. seeks 510(k) Premarket Notification for PeriFlux System 5000, which is a laser doppler system consisting of main units and functional units
However, according to FDA Modernization Act, devices that fall under class I and II are exempted from premarket approval, thus, the time required for regulatory approval is reduced, which brings down the costs. The increasing FDA approvals attracts the end users, and this expected to boost the demand for skin perfusion pressure testing devices.
Skin pressure perfusion is the most advanced method for the assessment of wound healing in limb ischemia and peripheral artery diseases. This method requires highly trained or skilled professionals to operate the device. Since it is fully-automated and provides quantitative evaluation of microcirculation, its operability requires skilled people, which as a result may limit the use of skin perfusion pressure testing devices.
Thus, reliability and reproducible measurement is highly dependent on a skilled technician or operator who interprets the results of skin perfusion pressure measurement. Lack of skilled professionals therefore can create significant challenges for the market.
The healthcare system of the U.S. is well renowned for its advanced infrastructure and expenditure. The care regime of the care centers and hospitals are monitored by various regulatory rules and insurance policies. The massive hospital bills incurred other than the Medicare have been influencing the market in the country.
Government and regulatory bodies of the U.S. are adopting several cost-containment plans to reduce their healthcare burden. The shift from a volume to a value-based system is majorly driven by the various measures undertaken by providers, governments, biotechnology companies, and insurance payers. Some of the measures are outcome-based profits, pricing, risk sharing, competitive tendering, and price control.
A value-based healthcare system will not only provide improved outcomes through integrated care pathways, but also levy pricing pressure on medical device companies, and this is likely to impact investments on the R&D of advanced medical treatment technologies.
Furthermore, due to the higher prevalence of critical limb ischemia and peripheral arterial disease in U.S., several manufactures are conducting campaigns to raise general awareness among people related to these diseases. This is likely to support the overall market growth in the country. For example, Amputee Coalition of America (NGO) launched a campaign in April 2018 to raise limb loss awareness among people.
The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, the country’s healthcare spending accounted for 11.7% of the GDP. Furthermore, health expenditure was expected to surge to 407.4 billion Euros by 2019, presenting a lucrative landscape for the expansion of the skin perfusion pressure testing devices.
Also presence of companies such as ELCAT GmbH is supporting the expansion in Germany. The company has been investing significantly in expansion efforts. Growth strategies adopted by these companies are expected to aid the expansion in Germany.
Since 2009, health insurance has been made mandatory for all citizens of the country. According to National Center for Biotechnology Information (NCBI), a total of 70 million people, which roughly covers 85% of the population are covered by statutory health insurance. Another 11% population of Germany is covered by substitutive private health insurance. Conducive reimbursement policies and regulatory scenario are presenting attractive opportunities for growth.
Increasing disposable income can have significant impact in development of economy in emerging countries which results in affordability of proper healthcare treatment. China’s per capita disposable income reached (about 4,961 U.S. dollars) in 2020, more than double the level in 2010.
Potential for high healthcare insurance and rising disposable income will contribute to increase in affordability of healthcare services. This will also allow improved accessibility to expensive equipment for treatment of diseases. The market in China is expected to witness significant growth at a CAGR of around 5.4%.
Both chronic limb ischemia and peripheral artery disease impose serious threats to the population. Lack of awareness of diseases and lack of proper treatment leads to high prevalence of these diseases. Due to limited campaigning about the assessment of these diseases, there seems to occur less usage of these devices in hospitals in South Africa.
Moreover, poor healthcare facilities in some countries restrain the growth of the skin perfusion pressure testing market. Despite financial burden, government in South Africa is adopting various initiatives to spread create awareness among population, which is expected to enable steady growth in the market.
The market in South Africa is expected to witness sluggish growth at a CAGR of just around 3.8%.
Laser dopplers are widely used for skin perfusion pressure testing. Due to easy operability and noninvasiveness, most physicians opt for laser dopplers. Since laser dopplers are costly, manufacturers provide reimbursements for such devices.
However, the use of laser dopplers is not only limited to the measurement of skin perfusion pressure. These can be used in a wide range of testing parameters such as toe blood pressure (TBP), post occlusive reactive hyperaemia (PORH), ankle brachial pressure index (ABPI), and others.
For example, Moor Instrument’s new moorVMS-VASC 2.0 monitoring system is designed to test pulse volume recording (PVR) and other parameters apart from skin perfusion pressure.
The portable devices segment will continue to grow and dominate the market during the forecast period. According to FMI, the segment is expected to hold around 73% of the market share, in terms of modality, by the end of 2030. A portable device is a wearable or hand-held device. This is designed for easy usage, to be able to move or carry it from one place to another, thus its ease of operability, makes the device most widely adopted devices in the market.
Hospitals have been dominating the market as key end users because it receives higher footfall of patients. Besides this, hospitals have more advanced infrastructure to support advance equipment. Backed by these factors, FMI forecasts hospitals to continue dominating the market and account for 34.7% of the overall share in 2021.
Most of the medical device companies are currently focusing on designing laser doppler since it has gain much popularity in assessment of wound healing.
For example, Moor Instruments has design moorVMS-VASC 2.0 laser doppler system.
Moreover, the manufactures are focusing on getting stamp of approvals for their product and also entering into partnership and collaboration agreement to expand their product portfolio in different countries globally.
For instance, in April 2016, Perimed AB announced FDA approval for PeriFlux 6000.
Some of the leading companies operating in the market are:
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
| Attribute | Details |
|---|---|
| Forecast Period | 2020 to 2030 |
| Historical Data Available for | 2015 to 2019 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania Middle East & Africa |
| Key Countries Covered | USA, Canada, Germany, UK, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
| Key Segments Covered | Product Type, Modality, End User, and Region |
| Key Companies Profiled | Vasamed Incorporated; Moor Instruments; Perimed AB; ELCAT GmbH; ATYS Medical; Viasonix; Promed Group |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The U.S. currently leads the global market for skin perfusion pressure testing devices. Sales in the U.S. will be over 34% of total global demand throughout the forecast period.
Laser doppler comprises the dominant segment as compared to other products such as photoplethysmography due to ease of operability and noninvasiveness.
Some of the leading companies offering skin perfusion pressure testing devices are Vasamed Incorporated, Moor Instruments, Perimed AB, ELCAT GmbH, ATYS Medical, Viasonix, Promed Group, and others.
Hospitals are leading the end user segment of the skin perfusion pressure testing devices market owing to their advanced medical facilities and higher flow of patients for diagnosis and treatment.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption & Awareness Analysis
4.2. Product Features Vs. Modality Matrix
4.3. Key Strategies by Service Providers
4.4. Reimbursement Scenario
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Shift towards non-invasive procedures
5.2.2. Increasing use of laser doppler
5.2.3. Growing incidences of chronic limb ischemia (CLI)
5.2.4. Rising demand for skin perfusion pressure (SPP)
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunities
6. COVID19 Crisis Impact Analysis
6.1. Current COVID-19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product Type
6.4.2. Revenue By Country
6.5. 2020 Market Scenario
6.6. Quarter by Quarter Forecast
6.7. Projected recovery Quarter
6.8. Recovery Scenario - Short term, Midterm and Long Term Impact
7. Global Skin Perfusion Pressure Testing Devices Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Opportunity Analysis, 2020-2030
8. Global Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015–2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030
8.3.1. Laser Doppler Skin Perfusion Pressure Testing Devices
8.3.2. Photoplethysmography Skin Perfusion Pressure Testing Devices
8.3.3. Consumables
8.3.3.1. Pressure Cuff Controller
8.3.3.2. Fibre Optic Probe
8.4. Market Attractiveness Analysis By Product Type
9. Global Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Modality
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Modality, 2015–2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Modality, 2020-2030
9.3.1. Portable Devices
9.3.2. Cart-based Devices
9.4. Market Attractiveness Analysis By Modality
10. Global Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Wound Care Centers
10.3.4. Vascular Laboratory
10.4. Market Attractiveness Analysis By End User
11. Global Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030, by Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product Type
12.3.3. By Modality
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Latin America Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product Type
13.3.3. By Modality
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Europe Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product Type
14.3.3. By Modality
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. South Asia Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product Type
15.3.3. By Modality
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. East Asia Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product Type
16.3.3. By Modality
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Oceania Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product Type
17.3.3. By Modality
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Product Type
18.3.3. By Modality
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Key and Emerging Countries Skin Perfusion Pressure Testing Devices Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Skin Perfusion Pressure Testing Devices Market Analysis
19.2.1. By Product Type
19.2.2. By Modality
19.2.3. By End User
19.3. Canada Skin Perfusion Pressure Testing Devices Market Analysis
19.3.1. By Product Type
19.3.2. By Modality
19.3.3. By End User
19.4. Mexico Skin Perfusion Pressure Testing Devices Market Analysis
19.4.1. By Product Type
19.4.2. By Modality
19.4.3. By End User
19.5. Brazil Skin Perfusion Pressure Testing Devices Market Analysis
19.5.1. By Product Type
19.5.2. By Modality
19.5.3. By End User
19.6. U.K. Skin Perfusion Pressure Testing Devices Market Analysis
19.6.1. By Product Type
19.6.2. By Modality
19.6.3. By End User
19.7. Germany Skin Perfusion Pressure Testing Devices Market Analysis
19.7.1. By Product Type
19.7.2. By Modality
19.7.3. By End User
19.8. France Skin Perfusion Pressure Testing Devices Market Analysis
19.8.1. By Product Type
19.8.2. By Modality
19.8.3. By End User
19.9. Italy Skin Perfusion Pressure Testing Devices Market Analysis
19.9.1. By Product Type
19.9.2. By Modality
19.9.3. By End User
19.10. Spain Skin Perfusion Pressure Testing Devices Market Analysis
19.10.1. By Product Type
19.10.2. By Modality
19.10.3. By End User
19.11. BENELUX Skin Perfusion Pressure Testing Devices Market Analysis
19.11.1. By Product Type
19.11.2. By Modality
19.11.3. By End User
19.12. Russia Skin Perfusion Pressure Testing Devices Market Analysis
19.12.1. By Product Type
19.12.2. By Modality
19.12.3. By End User
19.13. China Skin Perfusion Pressure Testing Devices Market Analysis
19.13.1. By Product Type
19.13.2. By Modality
19.13.3. By End User
19.14. Japan Skin Perfusion Pressure Testing Devices Market Analysis
19.14.1. By Product Type
19.14.2. By Modality
19.14.3. By End User
19.15. South Korea Skin Perfusion Pressure Testing Devices Market Analysis
19.15.1. By Product Type
19.15.2. By Modality
19.15.3. By End User
19.16. India Skin Perfusion Pressure Testing Devices Market Analysis
19.16.1. By Product Type
19.16.2. By Modality
19.16.3. By End User
19.17. ASEAN Skin Perfusion Pressure Testing Devices Market Analysis
19.17.1. By Product Type
19.17.2. By Modality
19.17.3. By End User
19.18. Australia Skin Perfusion Pressure Testing Devices Market Analysis
19.18.1. By Product Type
19.18.2. By Modality
19.18.3. By End User
19.19. New Zealand Skin Perfusion Pressure Testing Devices Market Analysis
19.19.1. By Product Type
19.19.2. By Modality
19.19.3. By End User
19.20. GCC Countries Skin Perfusion Pressure Testing Devices Market Analysis
19.20.1. By Product Type
19.20.2. By Modality
19.20.3. By End User
19.21. Turkey Skin Perfusion Pressure Testing Devices Market Analysis
19.21.1. By Product Type
19.21.2. By Modality
19.21.3. By End User
19.22. South Africa Skin Perfusion Pressure Testing Devices Market Analysis
19.22.1. By Product Type
19.22.2. By Modality
19.22.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. Regional Footprint by Players
20.3.2. Product Foot print by Players
20.3.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive (Tentative List)
21.3.1. Vasamed Incorporated
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Product Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Moor Instruments
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Product Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Perimed AB
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Product Strategy
21.3.3.5.3. Channel Strategy
21.3.4. ELCAT GmbH
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Product Strategy
21.3.4.5.3. Channel Strategy
21.3.5. ATYS Medical
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Product Strategy
21.3.5.5.3. Channel Strategy
21.3.6. Viasonix
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Product Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Promed Group
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Product Strategy
21.3.7.5.3. Channel Strategy
Explore Healthcare Insights
View Reports
Skin Perfusion Pressure Testing Devices Market
